父母心理社会变量和T1D儿科年龄的血糖控制:系统性审查
Vasco Costa1, Bárbara Pereira2, Susana R Patton3
1William James Center for Research, Ispa-Instituto Universitário, Lisboa, Portugal. 26054@alunos.ispa.pt.
Current diabetes reports
|December 16, 2024
概括
父母的心理社会因素,如压力和对低血糖的恐惧,显著影响1型糖尿病 (T1D) 儿童的血糖控制. 针对父母福祉的干预措施对于改善儿童健康结果至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 心理社会健康 心理健康
- 糖尿病管理 糖尿病管理
背景情况:
- 在幼儿中管理1型糖尿病 (T1D) 对父母来说是一个重大挑战.
- 父母的心理调整与儿科血糖结果密切相关.
- 现有研究强调了T1D护理中父母-子女动态的复杂性.
研究的目的:
- 系统地审查和综合有关父母心理社会因素和1-10岁儿童血糖结果之间的联系的证据.
- 确定影响儿科T1D血糖控制的关键家长心理社会变量.
- 总结目前关于父母压力,对低血糖的恐惧,家庭冲突和孩子的HbA1c水平之间的关系的发现.
主要方法:
- 按照PRISMA指南进行的系统文献审查.
- 在2019年至2024年期间,在四个主要数据库中进行的搜索.
- 纳入标准侧重于对1型糖尿病1-10岁儿童的父母心理社会因素和血糖结果的研究.
主要成果:
- 在最终分析中包括了五项研究,确定了父母心理社会变量与儿童血糖结果之间的直接关联.
- 研究结果表明,家长因素对儿童血糖控制的影响主要是单向的.
- 研究的特定父母心理社会变量包括对低血糖的恐惧,压力和家庭冲突.
结论:
- 父母的心理社会福祉是T1D儿童血糖结果的关键决定因素.
- 需要进一步的研究来探索父母因素和儿童血糖控制之间的纵向相互作用.
- 实施家长心理干预可能对于优化血糖管理和改善儿科T1D的健康结果至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Pathophysiology of Diabetes
862
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
862
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Management and Pharmacotherapy
234
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
234
Diabetes: Symptoms, Diagnosis, and Complications
503
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
503
Insulin: Dosing Regimen and Adverse Effects
142
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
142


